PageU1UofU822
TEST BANK U
Katzung's Basic and Clinical Pharm
U U U U
acology, 16th Edition
U U U
by Todd W. Vanderah, Chapters 1 - 66
U U U U U U U U
Katzung'sUBasicUandUClinicalUPharmacology
, PageU2UofU822
Table of Contents
U U
1.UIntroduction:UTheUNatureUofUDrugsU&UDrugUDevelopmentU&URegulation
2.UDrugUReceptorsU&UPharmacodynamics
3.UPharmacokineticsU&UPharmacodynamics:URationalUDosingU&UtheUTimeUCourseUofUDrugUAction
4.UDrugUBiotransformation
5.UPharmacogenomics
6.UIntroductionUtoUAutonomicUPharmacology
7.UCholinoceptor-ActivatingU&UCholinesterase-InhibitingUDrugs
8.UCholinoceptor-BlockingUDrugs
9.UAdrenoceptorUAgonistsU&USympathomimeticUDrugs
10.UAdrenoceptorUAntagonistUDrugs
11.UAntihypertensiveUAgents
12.UVasodilatorsU&UtheUTreatmentUofUAnginaUPectoris
13.UDrugsUUsedUinUHeartUFailure
14.UAgentsUUsedUinUCardiacUArrhythmias
15.UDiureticUAgents
16.UHistamine,USerotonin,U&UtheUErgotUAlkaloids
17.UVasoactiveUPeptides
18.UTheUEicosanoids:UProstaglandins,UThromboxanes,ULeukotrienes,U&URelatedUCompounds
19.UNitricUOxide
20.UDrugsUUsedUinUAsthma
21.UIntroductionUtoUtheUPharmacologyUofUCNSUDrugs
22.USedative-HypnoticUDrugs
23.UTheUAlcohols
24.UAntiseizureUDrugs
25.UGeneralUAnesthetics
26.ULocalUAnesthetics
27.USkeletalUMuscleURelaxants
28.UPharmacologicUManagementUofUParkinsonismU&UOtherUMovementUDisorders
29.UAntipsychoticUAgentsU&ULithium
30.UAntidepressantUAgents
31.UOpioidUAgonistsU&UAntagonists
32.UDrugsUofUAbuse
33.UAgentsUUsedUinUCytopenias;UHematopoieticUGrowthUFactors
34.UDrugsUUsedUinUDisordersUofUCoagulation
35.UAgentsUUsedUinUDyslipidemia
36.UNonsteroidalUAnti-InflammatoryUDrugs,UDisease-
ModifyingUAntirheumaticUDrugs,UNonopioidUAnalgesics,U&UDrugsUUsedUinUGout
37.UHypothalamicU&UPituitaryUHormones
Katzung'sUBasicUandUClinicalUPharmacology
, PageU3UofU822
38.UThyroidU&UAntithyroidUDrugs
39.UAdrenocorticosteroidsU&UAdrenocorticalUAntagonists
40.UTheUGonadalUHormonesU&UInhibitors
41.UPancreaticUHormonesU&UAntidiabeticUDrugs
42.UAgentsUThatUAffectUBoneUMineralUHomeostasis
43.UBeta-LactamU&UOtherUCellUWall-U&UMembrane-ActiveUAntibiotics
44.UTetracyclines,UMacrolides,UClindamycin,UChloramphenicol,UStreptogramins,U&UOxazolidinones
45.UAminoglycosidesU&USpectinomycin
46.USulfonamides,UTrimethoprim,U&UQuinolones
47.UAntimycobacterialUDrugs
48.UAntifungalUAgents
49.UAntiviralUAgents
50.UMiscellaneousUAntimicrobialUAgents;UDisinfectants,UAntiseptics,U&USterilants
51.UClinicalUUseUofUAntimicrobialUAgents
52.UAntiprotozoalUDrugs
53.UClinicalUPharmacologyUofUtheUAntihelminthicUDrugs
54.UCancerUChemotherapy
55.UImmunopharmacology
56.UIntroductionUtoUToxicology:UOccupationalU&UEnvironmental
57.UHeavyUMetalUIntoxicationU&UChelators
58.UManagementUofUtheUPoisonedUPatient
59.USpecialUAspectsUofUPerinatalU&UPediatricUPharmacology
60.USpecialUAspectsUofUGeriatricUPharmacology
61.UDermatologicUPharmacology
62.UDrugsUUsedUinUtheUTreatmentUofUGastrointestinalUDiseases
63.UTherapeuticU&UToxicUPotentialUofUOver-the-CounterUAgents
64.UDietaryUSupplementsU&UHerbalUMedications
65.URationalUPrescribingU&UPrescriptionUWriting
66.UImportantUDrugUInteractionsU&UTheirUMechanismsU
Katzung'sUBasicUandUClinicalUPharmacology
, PageU4UofU822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
U U U U U U U U U U U
1.
AUnurseUworkingUinUradiologyUadministersUiodineUtoUaUpatientUwhoUisUhavi
ngUaUcomputedUtomographyU(CT)Uscan.UTheUnurseUworkingUonUtheUoncologyU
unitUadministersUchemotherapyUtoUpatientsUwhoUhaveUcancer.UAtUtheUPublicUH
ealthUDepartment,UaUnurseUadministersUaUmeasles-mumps-
rubellaU(MMR)UvaccineUtoUaU14-month-
oldUchildUasUaUroutineUimmunization.UWhichUbranchUofUpharmacologyUbestUde
scribesUtheUactionsUofUallUthreeU nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
PharmacologyUisUtheUstudyUofUtheUbiologicUeffectsUofUchemicals.UNursesUareUi
nvolvedUwithUclinicalUpharmacologyUorUpharmacotherapeutics,UwhichUisUaUbr
anchUofUpharmacologyUthatUdealsUwithUtheUusesUofUdrugsUtoUtreat,Uprevent,Uan
dUdiagnoseUdisease.UTheUradiologyUnurseUisUadministeringUaUdrugUtoUhelpUdia
gnoseUaUdisease.UTheUoncologyUnurseUisUadministeringUaUdrugUtoUhelpUtreatUaU
disease.UPharmacoeconomicsUincludesUanyUcostsUinvolvedUinUdrugU therapy.
PharmacodynamicsUinvolvesUhowUaUdrugUaffectsUtheUbodyUan
dUpharmacokineticsUisUhowUtheUbodyUactsUonUtheUbody.
2.
AUphysicianUhasUorderedUintramuscularU(IM)UinjectionsUofUmorphine,UaUna
rcotic,UeveryU4UhoursUasUneededUforUpainUinUaUmotorUvehicleUaccidentUvictim.U
TheUnurseUisUawareUthisUdrugUhasUaUhighUabuseUpotential.UUnderUwhatUcatego
ryUwouldUmorphineUbeUclassified?
A) ScheduleUI
B) ScheduleUII
Katzung'sUBasicUandUClinicalUPharmacology
TEST BANK U
Katzung's Basic and Clinical Pharm
U U U U
acology, 16th Edition
U U U
by Todd W. Vanderah, Chapters 1 - 66
U U U U U U U U
Katzung'sUBasicUandUClinicalUPharmacology
, PageU2UofU822
Table of Contents
U U
1.UIntroduction:UTheUNatureUofUDrugsU&UDrugUDevelopmentU&URegulation
2.UDrugUReceptorsU&UPharmacodynamics
3.UPharmacokineticsU&UPharmacodynamics:URationalUDosingU&UtheUTimeUCourseUofUDrugUAction
4.UDrugUBiotransformation
5.UPharmacogenomics
6.UIntroductionUtoUAutonomicUPharmacology
7.UCholinoceptor-ActivatingU&UCholinesterase-InhibitingUDrugs
8.UCholinoceptor-BlockingUDrugs
9.UAdrenoceptorUAgonistsU&USympathomimeticUDrugs
10.UAdrenoceptorUAntagonistUDrugs
11.UAntihypertensiveUAgents
12.UVasodilatorsU&UtheUTreatmentUofUAnginaUPectoris
13.UDrugsUUsedUinUHeartUFailure
14.UAgentsUUsedUinUCardiacUArrhythmias
15.UDiureticUAgents
16.UHistamine,USerotonin,U&UtheUErgotUAlkaloids
17.UVasoactiveUPeptides
18.UTheUEicosanoids:UProstaglandins,UThromboxanes,ULeukotrienes,U&URelatedUCompounds
19.UNitricUOxide
20.UDrugsUUsedUinUAsthma
21.UIntroductionUtoUtheUPharmacologyUofUCNSUDrugs
22.USedative-HypnoticUDrugs
23.UTheUAlcohols
24.UAntiseizureUDrugs
25.UGeneralUAnesthetics
26.ULocalUAnesthetics
27.USkeletalUMuscleURelaxants
28.UPharmacologicUManagementUofUParkinsonismU&UOtherUMovementUDisorders
29.UAntipsychoticUAgentsU&ULithium
30.UAntidepressantUAgents
31.UOpioidUAgonistsU&UAntagonists
32.UDrugsUofUAbuse
33.UAgentsUUsedUinUCytopenias;UHematopoieticUGrowthUFactors
34.UDrugsUUsedUinUDisordersUofUCoagulation
35.UAgentsUUsedUinUDyslipidemia
36.UNonsteroidalUAnti-InflammatoryUDrugs,UDisease-
ModifyingUAntirheumaticUDrugs,UNonopioidUAnalgesics,U&UDrugsUUsedUinUGout
37.UHypothalamicU&UPituitaryUHormones
Katzung'sUBasicUandUClinicalUPharmacology
, PageU3UofU822
38.UThyroidU&UAntithyroidUDrugs
39.UAdrenocorticosteroidsU&UAdrenocorticalUAntagonists
40.UTheUGonadalUHormonesU&UInhibitors
41.UPancreaticUHormonesU&UAntidiabeticUDrugs
42.UAgentsUThatUAffectUBoneUMineralUHomeostasis
43.UBeta-LactamU&UOtherUCellUWall-U&UMembrane-ActiveUAntibiotics
44.UTetracyclines,UMacrolides,UClindamycin,UChloramphenicol,UStreptogramins,U&UOxazolidinones
45.UAminoglycosidesU&USpectinomycin
46.USulfonamides,UTrimethoprim,U&UQuinolones
47.UAntimycobacterialUDrugs
48.UAntifungalUAgents
49.UAntiviralUAgents
50.UMiscellaneousUAntimicrobialUAgents;UDisinfectants,UAntiseptics,U&USterilants
51.UClinicalUUseUofUAntimicrobialUAgents
52.UAntiprotozoalUDrugs
53.UClinicalUPharmacologyUofUtheUAntihelminthicUDrugs
54.UCancerUChemotherapy
55.UImmunopharmacology
56.UIntroductionUtoUToxicology:UOccupationalU&UEnvironmental
57.UHeavyUMetalUIntoxicationU&UChelators
58.UManagementUofUtheUPoisonedUPatient
59.USpecialUAspectsUofUPerinatalU&UPediatricUPharmacology
60.USpecialUAspectsUofUGeriatricUPharmacology
61.UDermatologicUPharmacology
62.UDrugsUUsedUinUtheUTreatmentUofUGastrointestinalUDiseases
63.UTherapeuticU&UToxicUPotentialUofUOver-the-CounterUAgents
64.UDietaryUSupplementsU&UHerbalUMedications
65.URationalUPrescribingU&UPrescriptionUWriting
66.UImportantUDrugUInteractionsU&UTheirUMechanismsU
Katzung'sUBasicUandUClinicalUPharmacology
, PageU4UofU822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
U U U U U U U U U U U
1.
AUnurseUworkingUinUradiologyUadministersUiodineUtoUaUpatientUwhoUisUhavi
ngUaUcomputedUtomographyU(CT)Uscan.UTheUnurseUworkingUonUtheUoncologyU
unitUadministersUchemotherapyUtoUpatientsUwhoUhaveUcancer.UAtUtheUPublicUH
ealthUDepartment,UaUnurseUadministersUaUmeasles-mumps-
rubellaU(MMR)UvaccineUtoUaU14-month-
oldUchildUasUaUroutineUimmunization.UWhichUbranchUofUpharmacologyUbestUde
scribesUtheUactionsUofUallUthreeU nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
PharmacologyUisUtheUstudyUofUtheUbiologicUeffectsUofUchemicals.UNursesUareUi
nvolvedUwithUclinicalUpharmacologyUorUpharmacotherapeutics,UwhichUisUaUbr
anchUofUpharmacologyUthatUdealsUwithUtheUusesUofUdrugsUtoUtreat,Uprevent,Uan
dUdiagnoseUdisease.UTheUradiologyUnurseUisUadministeringUaUdrugUtoUhelpUdia
gnoseUaUdisease.UTheUoncologyUnurseUisUadministeringUaUdrugUtoUhelpUtreatUaU
disease.UPharmacoeconomicsUincludesUanyUcostsUinvolvedUinUdrugU therapy.
PharmacodynamicsUinvolvesUhowUaUdrugUaffectsUtheUbodyUan
dUpharmacokineticsUisUhowUtheUbodyUactsUonUtheUbody.
2.
AUphysicianUhasUorderedUintramuscularU(IM)UinjectionsUofUmorphine,UaUna
rcotic,UeveryU4UhoursUasUneededUforUpainUinUaUmotorUvehicleUaccidentUvictim.U
TheUnurseUisUawareUthisUdrugUhasUaUhighUabuseUpotential.UUnderUwhatUcatego
ryUwouldUmorphineUbeUclassified?
A) ScheduleUI
B) ScheduleUII
Katzung'sUBasicUandUClinicalUPharmacology
